Recent Release | 01 Dec 2022
The State of the Nation: The UK Family Business Sector 2021–22
Economic Consulting Team
Oxford Economics
During the pandemic and in its aftermath, the UK family business sector has remained a core part of the UK economy. In this report, we present new insights about the sector and highlight its economic contribution.
The 4.8 million family firms in the UK made up 85.9% of all private sector businesses in 2020. Through their daily operations, they employed 13.9 million workers—51.5% of private sector employment. They also contributed £575 billion in GVA.
This latest report also presents new evidence on the effect of the coronavirus pandemic on family businesses, and how it impacted their operations and performance. It also looks to the future, outlining how family firms are feeling about the post-pandemic economy, and how they are considering issues such as Brexit, energy usage, and technology adoption.
About the team
Our Economic Consulting team are world leaders in quantitative economic analysis, working with clients around the globe and across sectors to build models, forecast markets and evaluate interventions using state-of-the art techniques. Lead consultants on this project were:
Ian Saxon
Associate Director, Economic Impact
Ankur Desai
Economist, Economic Impact
You might be interested in
The Eurozone economy should escape a recession this year
Our revamped modelling shows that a recession is not imminent for the Eurozone and the big four despite the extreme trade policy uncertainty.
Find Out More
Mastering Thought Leadership: Four Key Challenges and How to Overcome Them
Initiating a successful Thought Leadership program requires careful planning and coordination at the concept stage.
Find Out More
New US tariffs would push Eurozone’s economy to the brink of recession
The economic costs of the 50% tariffs to the Eurozone could amount to 0.3%–1.0% of the Eurozone’s GDP by the end of next year.
Find Out More
Four recession scenarios stalk the Eurozone’s fragile growth path
The Eurozone's recession risks remain elevated—possibly higher than those in the US—as its economic expansion is more fragile.
Find Out More